179 related articles for article (PubMed ID: 27052176)
21. p53 regulates the minimal promoter of the human topoisomerase IIalpha gene.
Sandri MI; Isaacs RJ; Ongkeko WM; Harris AL; Hickson ID; Broggini M; Vikhanskaya F
Nucleic Acids Res; 1996 Nov; 24(22):4464-70. PubMed ID: 8948636
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of topoisomerase IIα: novel function of wedelolactone.
Benes P; Knopfova L; Trcka F; Nemajerova A; Pinheiro D; Soucek K; Fojta M; Smarda J
Cancer Lett; 2011 Apr; 303(1):29-38. PubMed ID: 21315506
[TBL] [Abstract][Full Text] [Related]
23. The association between the p53/topoisomerase I and p53/ topoisomerase IIalpha immunophenotypes and the progression of ovarian carcinomas.
Bar JK; Grelewski P; Noga L; Rabczyński J; Gryboś M; Jeleń M
Adv Clin Exp Med; 2012; 21(1):35-42. PubMed ID: 23214297
[TBL] [Abstract][Full Text] [Related]
24. Smurf2-Mediated Stabilization of DNA Topoisomerase IIα Controls Genomic Integrity.
Emanuelli A; Borroni AP; Apel-Sarid L; Shah PA; Ayyathan DM; Koganti P; Levy-Cohen G; Blank M
Cancer Res; 2017 Aug; 77(16):4217-4227. PubMed ID: 28611047
[TBL] [Abstract][Full Text] [Related]
25. Maternal topoisomerase II alpha, not topoisomerase II beta, enables embryonic development of zebrafish top2a-/- mutants.
Sapetto-Rebow B; McLoughlin SC; O'Shea LC; O'Leary O; Willer JR; Alvarez Y; Collery R; O'Sullivan J; Van Eeden F; Hensey C; Kennedy BN
BMC Dev Biol; 2011 Nov; 11():71. PubMed ID: 22111588
[TBL] [Abstract][Full Text] [Related]
26. Myosin VI is differentially regulated by DNA damage in p53- and cell type-dependent manners.
Cho SJ; Chen X
J Biol Chem; 2010 Aug; 285(35):27159-27166. PubMed ID: 20576604
[TBL] [Abstract][Full Text] [Related]
27. Human topoisomerase IIalpha rapidly relaxes positively supercoiled DNA: implications for enzyme action ahead of replication forks.
McClendon AK; Rodriguez AC; Osheroff N
J Biol Chem; 2005 Nov; 280(47):39337-45. PubMed ID: 16188892
[TBL] [Abstract][Full Text] [Related]
28. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.
Liu D; Huang CL; Kameyama K; Hayashi E; Yamauchi A; Sumitomo S; Yokomise H
Cancer; 2002 Apr; 94(8):2239-47. PubMed ID: 12001123
[TBL] [Abstract][Full Text] [Related]
29. p53 orchestrates DNA replication restart homeostasis by suppressing mutagenic RAD52 and POLθ pathways.
Roy S; Tomaszowski KH; Luzwick JW; Park S; Li J; Murphy M; Schlacher K
Elife; 2018 Jan; 7():. PubMed ID: 29334356
[TBL] [Abstract][Full Text] [Related]
30. Gambogic acid inhibits the catalytic activity of human topoisomerase IIalpha by binding to its ATPase domain.
Qin Y; Meng L; Hu C; Duan W; Zuo Z; Lin L; Zhang X; Ding J
Mol Cancer Ther; 2007 Sep; 6(9):2429-40. PubMed ID: 17876042
[TBL] [Abstract][Full Text] [Related]
31. Mre11 Is Essential for the Removal of Lethal Topoisomerase 2 Covalent Cleavage Complexes.
Hoa NN; Shimizu T; Zhou ZW; Wang ZQ; Deshpande RA; Paull TT; Akter S; Tsuda M; Furuta R; Tsutsui K; Takeda S; Sasanuma H
Mol Cell; 2016 Nov; 64(3):580-592. PubMed ID: 27814490
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation.
Zhao H; Traganos F; Darzynkiewicz Z
Cell Cycle; 2008 Oct; 7(19):3048-55. PubMed ID: 18802408
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure-activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase IIα catalytic inhibitor.
Ahmad P; Woo H; Jun KY; Kadi AA; Abdel-Aziz HA; Kwon Y; Rahman AF
Bioorg Med Chem; 2016 Apr; 24(8):1898-908. PubMed ID: 26988802
[TBL] [Abstract][Full Text] [Related]
34. A cysteine-reactive alkyl hydroquinone modifies topoisomerase IIα, enhances DNA breakage, and induces apoptosis in cancer cells.
Lin TY; Huang CP; Au LC; Chang YW; Hu CY; Lin SB
Chem Res Toxicol; 2012 Nov; 25(11):2340-51. PubMed ID: 23088786
[TBL] [Abstract][Full Text] [Related]
35. Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription.
Tuduri S; Crabbé L; Conti C; Tourrière H; Holtgreve-Grez H; Jauch A; Pantesco V; De Vos J; Thomas A; Theillet C; Pommier Y; Tazi J; Coquelle A; Pasero P
Nat Cell Biol; 2009 Nov; 11(11):1315-24. PubMed ID: 19838172
[TBL] [Abstract][Full Text] [Related]
36. Oxocrebanine: A Novel Dual Topoisomerase inhibitor, Suppressed the Proliferation of Breast Cancer Cells MCF-7 by Inducing DNA Damage and Mitotic Arrest.
Yu L; Han S; Lang L; Song H; Zhang C; Dong L; Jia S; Zhang Y; Xiao D; Liu J; Xu Y; Zhang X
Phytomedicine; 2021 Apr; 84():153504. PubMed ID: 33611211
[TBL] [Abstract][Full Text] [Related]
37. A high-throughput fluorescence anisotropy-based assay for human topoisomerase II β-catalyzed ATP-dependent supercoiled DNA relaxation.
Shapiro AB; Austin CA
Anal Biochem; 2014 Mar; 448():23-9. PubMed ID: 24309019
[TBL] [Abstract][Full Text] [Related]
38. Arrest of replication fork progression at sites of topoisomerase II-mediated DNA cleavage in human leukemia CEM cells incubated with VM-26.
Catapano CV; Carbone GM; Pisani F; Qiu J; Fernandes DJ
Biochemistry; 1997 May; 36(19):5739-48. PubMed ID: 9153414
[TBL] [Abstract][Full Text] [Related]
39. Unprecedented citrinin trimer tricitinol B functions as a novel topoisomerase IIα inhibitor.
Du L; Liu HC; Fu W; Li DH; Pan QM; Zhu TJ; Geng MY; Gu QQ
J Med Chem; 2011 Aug; 54(16):5796-810. PubMed ID: 21761866
[TBL] [Abstract][Full Text] [Related]
40. Regulation of DNA topoisomerase IIalpha stability by the ECV ubiquitin ligase complex.
Yun J; Kim YI; Tomida A; Choi CH
Biochem Biophys Res Commun; 2009 Nov; 389(1):5-9. PubMed ID: 19695223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
